Onkologie Leer - Emden - Papenburg
Industry / private company
Location:
Leer / Emden / Papenburg,
Germany (DE)
ISNI: -
Advanced renal cell carcinoma: First results from the prospective research platform CARAT for patients with mRCC in Germany (2019)
Goebell P, Mueller L, Gruellich C, Reichert D, Boegemann M, Doerfel S, Von Der Heyde E, et al.
Conference contribution
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants (2017)
Hehlmann R, Lauseker M, Saussele S, Pfirrmann M, Krause S, Kolb HJ, Neubauer A, et al.
Journal article
A Cross-Sectional Investigation of Fatigue, Mucositis, Hand-Foot Syndrome and Dysgeusia in Advanced Renal Cell Carcinoma Treatment: Final Results From the FAMOUS Study (2016)
Goebell P, Mueller L, Hurtz HJ, Koska M, Busies S, Marschner N
Journal article
A cross-sectional investigation of fatigue in advanced renal cell carcinoma treatment: results from the FAMOUS study (2014)
Goebell P, Muench A, Mueller L, Hurtz HJ, Koska M, Busies S, Marschner N
Journal article